This is supported by the fact that a siRNA-mediated targeting of ABL/BCR strongly reduced the proliferation not only of an ALL cell line, but also of primary Ph+ PD-LTCs, which was accompanied by the induction of apoptosis. Here, ABL1 is linked to acute lymphoblastic leukemia.